gdc
Submit Your Story
Subscribe

Personalized Medicine

Understanding Hereditary Biomarkers Versus Tumor-Specific Biomarkers—What’s the Difference?
Cancer BiomarkersGenetics & CancerPersonalized Medicine
Understanding Hereditary Biomarkers Versus Tumor-Specific Biomarkers—What’s the Difference?
By Lavinia Dobrea, RN, MS, OCNLavinia Dobrea, RN, MS, OCN, Kate Partynski, MS
May 2019 Volume 5 – Biomarkers & Molecular Testing
One-size-fits-all medicine is a thing of the past. Cancer, at its core, is a genetic disease. Today’s advances in cancer research mean that doctors can now tailor a personalized treatment to the patient’s specific cancer type.
Telling Patients About CAR T-Cell Therapy
ImmunotherapyLeukemiaLymphomaPersonalized Medicine
Telling Patients About CAR T-Cell Therapy
By Claire White, BSN, RN, CPHON
Video Library
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
What Is Personalized Medicine, and Why Is It Important for Cancer Treatment? Interview with Dr. Ross Maclean
ImmunotherapyPersonalized Medicine
What Is Personalized Medicine, and Why Is It Important for Cancer Treatment? Interview with Dr. Ross Maclean
October 2017 Vol 3 No 5
An interview with Ross Maclean, MD, PhD, Senior Vice President, Head of Medical at Precision Health Economics, Princeton, NJ, about the importance of personalized medicine in the treatment of cancer.

Results 1 - 3 of 3

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country